Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry
Trial ID or NCT#
NCT01144780
Status
NOT RECRUITING
Purpose
The objective of this study is to better understand the underlying pathogenetic mechanisms of myeloproliferative disorders (MPDs). We will collect peripheral blood samples from MPD patients and utilize multiparameter phospho-specific flow cytometry to investigate dysregulated signaling in blood cells from these patients. This will provide deeper insights into the pathogenesis of MPDs and may lead to the identification of novel targets for therapeutic intervention.
Official Title
Investigation of Dysregulated Signaling in Myeloproliferative Disorders Via Multiparameter Phospho-specific Flow Cytometry
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
- Any patient who carries a diagnosis of a myeloproliferative disorder (MPD).
Exclusion Criteria:
- Any patient who is not willing to give consent.
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Stephen Oh
650-723-7875
View on ClinicalTrials.gov
